DE69100314T2 - Behandlung von Clostridium difficile Diarrhöe und Pseudomembrankolitis. - Google Patents
Behandlung von Clostridium difficile Diarrhöe und Pseudomembrankolitis.Info
- Publication number
- DE69100314T2 DE69100314T2 DE91301955T DE69100314T DE69100314T2 DE 69100314 T2 DE69100314 T2 DE 69100314T2 DE 91301955 T DE91301955 T DE 91301955T DE 69100314 T DE69100314 T DE 69100314T DE 69100314 T2 DE69100314 T2 DE 69100314T2
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- clostridium difficile
- difficile diarrhea
- pseudomembrane
- colitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2056596A JP2961182B2 (ja) | 1990-03-09 | 1990-03-09 | クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69100314D1 DE69100314D1 (de) | 1993-10-07 |
DE69100314T2 true DE69100314T2 (de) | 1993-12-16 |
Family
ID=13031585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE91301955T Expired - Lifetime DE69100314T2 (de) | 1990-03-09 | 1991-03-08 | Behandlung von Clostridium difficile Diarrhöe und Pseudomembrankolitis. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0446069B1 (de) |
JP (1) | JP2961182B2 (de) |
KR (1) | KR0145553B1 (de) |
DE (1) | DE69100314T2 (de) |
HU (1) | HUT61478A (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4572185B2 (ja) * | 2006-08-28 | 2010-10-27 | ミヤリサン製薬株式会社 | 酪酸菌及び/又は乳酸菌を含有してなる消化管洗浄助剤 |
EP2613802A4 (de) * | 2010-09-10 | 2014-03-26 | Viropharma Inc | Bakteriotherapie mit einer clostridien-umgebung sowie entsprechende formulierungen und verfahren zu ihrer herstellung und verwendung |
EP2836224A4 (de) | 2012-02-29 | 2015-12-16 | Ethicon Endo Surgery Inc | Zusammensetzungen von biozönose und zugehörige verfahren |
SG10201704035TA (en) * | 2012-11-23 | 2017-06-29 | Seres Therapeutics Inc | Synergistic bacterial compositions and methods of production and use thereof |
US8906668B2 (en) | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
EP2951285A4 (de) | 2013-02-04 | 2016-10-26 | Seres Therapeutics Inc | Zusammensetzungen und verfahren zur hemmung des wachstums pathogener bakterien |
US10973861B2 (en) | 2013-02-04 | 2021-04-13 | Seres Therapeutics, Inc. | Compositions and methods |
EP2967077A4 (de) | 2013-03-15 | 2016-09-14 | Seres Therapeutics Inc | Netzwerkbasierte mikrobielle zusammensetzungen und verfahren |
AU2014352643A1 (en) | 2013-11-25 | 2016-06-30 | Seres Therapeutics, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
US9956282B2 (en) | 2013-12-16 | 2018-05-01 | Seres Therapeutics, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
GB2551642B (en) | 2014-10-31 | 2020-09-23 | Pendulum Therapeutics Inc | Methods and compositions relating to microbial treatment and diagnosis of disorders |
RU2020110462A (ru) | 2017-08-14 | 2021-09-16 | Серес Терапеутикс, Инк. | Композиции и способы для лечения холестатического заболевания |
WO2019046646A1 (en) | 2017-08-30 | 2019-03-07 | Whole Biome Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2678M (fr) * | 1962-07-11 | 1964-07-27 | Taisho Pharmaceutical Co Ltd | Application comme régulateur intestinal d'une préparation a base de clostridium butyricum en thérapeutique. |
GB1190386A (en) * | 1966-06-28 | 1970-05-06 | Green Cross Corp | Process for producing the Lactic Acid Bacteria Drugs |
-
1990
- 1990-03-09 JP JP2056596A patent/JP2961182B2/ja not_active Expired - Lifetime
-
1991
- 1991-03-05 HU HU91705A patent/HUT61478A/hu unknown
- 1991-03-07 KR KR1019910003689A patent/KR0145553B1/ko not_active IP Right Cessation
- 1991-03-08 DE DE91301955T patent/DE69100314T2/de not_active Expired - Lifetime
- 1991-03-08 EP EP91301955A patent/EP0446069B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0446069A1 (de) | 1991-09-11 |
KR910016338A (ko) | 1991-11-05 |
DE69100314D1 (de) | 1993-10-07 |
JPH0656679A (ja) | 1994-03-01 |
KR0145553B1 (ko) | 1998-08-17 |
HUT61478A (en) | 1993-01-28 |
JP2961182B2 (ja) | 1999-10-12 |
HU910705D0 (en) | 1991-09-30 |
EP0446069B1 (de) | 1993-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69122298D1 (de) | Behandlung von Clostridium difficile Diarrhöe und pseudomembraner Dickdarmentzündung | |
DE69100314D1 (de) | Behandlung von Clostridium difficile Diarrhöe und Pseudomembrankolitis. | |
DE68909219D1 (de) | Behandlung von obesitas. | |
DE69014030T3 (de) | Mittel für die Verhütung und Behandlung von Diarrhöe. | |
DE297436T1 (de) | Behandlung von hyperhidrose, ichtyosis und faltenbildung. | |
DE69008010T2 (de) | Sauerstoffdelignifizierung und enzymatische Behandlung. | |
DE69127996T2 (de) | Bistabiler DMD-Ansteuerschaltkreis und Ansteuerverfahren | |
DE69220679D1 (de) | Antibakterielles mittel und behandlung von gegenständen mit diesem | |
DE201165T1 (de) | Arzneimittel zur behandlung von emesis, anxietas und "irritable bowel syndrome". | |
DE3788691T2 (de) | Verhütung von Fusariumkrankheiten und Mikroorganismen dafür. | |
DE69429160T2 (de) | Behandlung von textilprodukt | |
DE588928T1 (de) | Erzeugung und simulation von wissenssystemen. | |
DE69427485D1 (de) | Verbindungen, zubereitungen und behandlung von allergien und entzündungen | |
NO911431D0 (no) | Behandling av stoffer. | |
DE69116033D1 (de) | Reaktor zur Behandlung von Halbleiterscheiben. | |
DE69113700T2 (de) | Alpha-(Alkylcyclohexyloxy)-beta-alkanole und diese enthaltende Riechstoffzusammensetzungen. | |
ATE92542T1 (de) | Azeotropaehnliche zusammensetzungen von 1,1dichlor-2,2,2-trifluoraethan und 1,1-dochlor-1fluor|than. | |
DE69009069T2 (de) | Aufbereitung von häuslichem und industriellem abwasser. | |
DE68923219T2 (de) | Behandlung von Abfällen. | |
NO892505D0 (no) | Behandling av vandige dispersjoner. | |
NO871389L (no) | Apparat til sterilisering av gjenstander. | |
DE3767399D1 (de) | Herstellung und verpacken von struempfen. | |
NO913661D0 (no) | Anordning og fremgangsmaate for dosering av vaskemiddelkompositter. | |
FR2664516B1 (fr) | Four de maintien en temperature et de traitement metallurgique. | |
DE69124686T2 (de) | Wärmebehandlung von Halbleiterbauelementen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |